NPPB and hydrops fetalis: In the PIONEER‐HF trial, in‐hospital initiation of ARNI in stable patients as early as 24  hours after initial presentation with AHF (LVEF ≤ 40%) was safe and associated with substantial and rapid reductions in NT‐proBNP concentration and cardiovascular death or HHF as compared to enalapril.63, 64